Back to Search
LAJOS PUSZTAI, M.D., D.PHIL
M.D., D.PHIL
Medical Oncology Physician
NPI: 1437241510IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K3407(TX)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1987
Research & Publications (20)
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
PMID 19603265·Breast Cancer Res Treat·2010
8-other
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
PMID 19667268·J Clin Oncol·2009
8-other
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
PMID 19147748·Clin Cancer Res·2009
8-other
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
PMID 19346299·Oncologist·2009
6-review
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
PMID 19596702·Ann Oncol·2009
8-other
Understanding the structure of aqueous cesium chloride solutions by combining diffraction experiments, molecular dynamics simulations, and reverse Monte Carlo modeling.
PMID 19588949·J Phys Chem B·2009
8-other
Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer.
PMID 19381845·Clin Exp Metastasis·2009
6-review
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
PMID 19272155·Breast Cancer Res·2009
8-other
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
PMID 19364972·J Clin Oncol·2009
8-other
Nanometer range correlations between molecular orientations in liquids of molecules with perfect tetrahedral shape: CCl(4), SiCl(4), GeCl(4), and SnCl(4).
PMID 19222280·J Chem Phys·2009
8-other
Benchmarking polarizable molecular dynamics simulations of aqueous sodium hydroxide by diffraction measurements.
PMID 19209921·J Phys Chem A·2009
8-other
Direct comparison of logistic regression and recursive partitioning to predict chemotherapy response of breast cancer based on clinical pathological variables.
PMID 19152025·Breast Cancer Res Treat·2009
4-observational
Solvation force between surfaces modified by tethered chains: a density functional approach.
PMID 19355745·J Chem Phys·2009
8-other
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
PMID 18667396·Ann Oncol·2008
4-observational
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
PMID 18676830·Cancer Res·2008
8-other
Comparison of interaction potentials of liquid water with respect to their consistency with neutron diffraction data of pure heavy water.
PMID 19045382·J Chem Phys·2008
8-other
Advances in translational research in breast cancer; a bridge to future therapies.
PMID 19028087·Eur J Cancer·2008
8-other
Are short-term or long-term recurrence rates more important in breast cancer screening?
PMID 18765708·Ann Intern Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 YORK STREET
NEW HAVEN, CT 06520 - Phone
- (203) 200-5250
Quick Facts
- NPI
- 1437241510
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile